Prior chemotherapy
| Unique patient ID . | Diagnosis . | No. of prior regimens . | Chemotherapy . | Radiation . |
|---|---|---|---|---|
| Solid tumor patients | ||||
| 3 | Esophageal cancer | 1 | 1. 5-FU/cisplatin | Yes |
| 4 | Hepatocellular | 0 | No | |
| 5 | Neuroendocrine | 2 | 1. VP-16/cisplatin | No |
| 2. Carbo/Taxol/VP-16 | ||||
| 7 | Adrenocortical | 1 | 1. Mitotane | Yes |
| 10 | Sarcoma | 0 | Yes | |
| 13 | Melanoma | 0 | Yes | |
| 15 | Lung | 3 | 1. Cisplatin/etoposide | No |
| 2. Topotecan | ||||
| 3. Taxol/Carbo | ||||
| 16 | Pancreatic | 1 | 1. Taxol | Yes |
| 17 | Renal cell | 0 | Yes | |
| 18 | Esophageal | 3 | 1. Cisplatin/5-FU | Yes |
| 2. Taxol/5FU | ||||
| 3. Camptosar | ||||
| 19 | Lung | 5 | 1. Taxol/carbo | Yes |
| 2. Navelbine | ||||
| 3. Gemcitabine/Herceptin | ||||
| 4. Camptosar | ||||
| 5. Taxol | ||||
| 21 | Lung | 1 | 1. Taxol/Carbo | Yes |
| 22 | Melanoma | 3 | 1. Interferon | Yes |
| 2. Vaccine/IL-2 | ||||
| 3. Dacarbazine | ||||
| Hematologic malignancy patients | ||||
| 1 | Lymphoma Large cell Follicular mixed | 4 | 1. Cytoxan/vincristine/Adriamycin/ prednisone (CHOP) 2. Etoposide/Solu-Medrol/ARA-C/ cisplatin (ESHAP) 3. Cytoxan 4. Autologous stem cell transplantation (BMT) (Cytoxan/etoposide/BCNU) | Yes |
| 2 | Lymphoma large cell | 3 | 1. CHOP 2. ESHAP 3. Rituxan | Yes |
| 6 | Myeloma | 6 | 1. Melphalan/prednisone 2. Vincristine/Cytoxan/Adriamycin/ prednisone 3. Cytoxan 4. Auto BMT (busulfan/Cytoxan/thiotepa) 5. Interferon 6. Decadron/Cytoxan/etoposide/ prednisone | Yes |
| 8 | Myeloma | 3 | 1. VAD (vincristine/Adriamycin Decadron) 2. Cytoxan 3. Auto BMT (melphalan) | Yes |
| 9 | Chronic myelogenous leukemia | 2 | 1. Idarubicin/vincristine/prednisone 2. Allo BMT (Cytoxan/TBI) | Yes |
| 11 | Lymphoma large cell | 4 | 1. CHOP 2. Ifosfamide/carboplatin/etoposide (ICE) 3. ESHAP 4. CHOP | No |
| 12 | Lymphoma lymphoblastic | 3 | 1. CHOP 2. Cytoxan 3. Auto BMT (Cytoxan/BCNU/ etoposide) | No |
| 14 | Lymphoma large cell | 5 | 1. CHOP 2. ESHAP 3. ICE 4. Rituxan 5. Etoposide/prednisone/vincristine/ Cytoxan | Yes |
| 20 | Lymphoma large cell | 6 | 1. CHOP 2. ICE 3. Cytoxan 4. Auto BMT (Cytoxan/BCNU/etoposide) 5. Taxol/topotecan 6. Rituxan | No |
| 23 | CLL | 5 | 1. Fludarabine-Cytoxan 2. Solu-Medrol 3. Adriamycin-etoposide-vincristine 4. Chlorambucil 5. Rituxan | Yes |
| 24 | Lymphoma large cell | 2 | 1. CHOP 2. ESHAP | Yes |
| 25 | AML | 3 | 1. Idarubicin/ARA-C | No |
| 2. Mitoxantrone/etoposide | ||||
| 3. Daunorubicin/ARA-C | ||||
| Unique patient ID . | Diagnosis . | No. of prior regimens . | Chemotherapy . | Radiation . |
|---|---|---|---|---|
| Solid tumor patients | ||||
| 3 | Esophageal cancer | 1 | 1. 5-FU/cisplatin | Yes |
| 4 | Hepatocellular | 0 | No | |
| 5 | Neuroendocrine | 2 | 1. VP-16/cisplatin | No |
| 2. Carbo/Taxol/VP-16 | ||||
| 7 | Adrenocortical | 1 | 1. Mitotane | Yes |
| 10 | Sarcoma | 0 | Yes | |
| 13 | Melanoma | 0 | Yes | |
| 15 | Lung | 3 | 1. Cisplatin/etoposide | No |
| 2. Topotecan | ||||
| 3. Taxol/Carbo | ||||
| 16 | Pancreatic | 1 | 1. Taxol | Yes |
| 17 | Renal cell | 0 | Yes | |
| 18 | Esophageal | 3 | 1. Cisplatin/5-FU | Yes |
| 2. Taxol/5FU | ||||
| 3. Camptosar | ||||
| 19 | Lung | 5 | 1. Taxol/carbo | Yes |
| 2. Navelbine | ||||
| 3. Gemcitabine/Herceptin | ||||
| 4. Camptosar | ||||
| 5. Taxol | ||||
| 21 | Lung | 1 | 1. Taxol/Carbo | Yes |
| 22 | Melanoma | 3 | 1. Interferon | Yes |
| 2. Vaccine/IL-2 | ||||
| 3. Dacarbazine | ||||
| Hematologic malignancy patients | ||||
| 1 | Lymphoma Large cell Follicular mixed | 4 | 1. Cytoxan/vincristine/Adriamycin/ prednisone (CHOP) 2. Etoposide/Solu-Medrol/ARA-C/ cisplatin (ESHAP) 3. Cytoxan 4. Autologous stem cell transplantation (BMT) (Cytoxan/etoposide/BCNU) | Yes |
| 2 | Lymphoma large cell | 3 | 1. CHOP 2. ESHAP 3. Rituxan | Yes |
| 6 | Myeloma | 6 | 1. Melphalan/prednisone 2. Vincristine/Cytoxan/Adriamycin/ prednisone 3. Cytoxan 4. Auto BMT (busulfan/Cytoxan/thiotepa) 5. Interferon 6. Decadron/Cytoxan/etoposide/ prednisone | Yes |
| 8 | Myeloma | 3 | 1. VAD (vincristine/Adriamycin Decadron) 2. Cytoxan 3. Auto BMT (melphalan) | Yes |
| 9 | Chronic myelogenous leukemia | 2 | 1. Idarubicin/vincristine/prednisone 2. Allo BMT (Cytoxan/TBI) | Yes |
| 11 | Lymphoma large cell | 4 | 1. CHOP 2. Ifosfamide/carboplatin/etoposide (ICE) 3. ESHAP 4. CHOP | No |
| 12 | Lymphoma lymphoblastic | 3 | 1. CHOP 2. Cytoxan 3. Auto BMT (Cytoxan/BCNU/ etoposide) | No |
| 14 | Lymphoma large cell | 5 | 1. CHOP 2. ESHAP 3. ICE 4. Rituxan 5. Etoposide/prednisone/vincristine/ Cytoxan | Yes |
| 20 | Lymphoma large cell | 6 | 1. CHOP 2. ICE 3. Cytoxan 4. Auto BMT (Cytoxan/BCNU/etoposide) 5. Taxol/topotecan 6. Rituxan | No |
| 23 | CLL | 5 | 1. Fludarabine-Cytoxan 2. Solu-Medrol 3. Adriamycin-etoposide-vincristine 4. Chlorambucil 5. Rituxan | Yes |
| 24 | Lymphoma large cell | 2 | 1. CHOP 2. ESHAP | Yes |
| 25 | AML | 3 | 1. Idarubicin/ARA-C | No |
| 2. Mitoxantrone/etoposide | ||||
| 3. Daunorubicin/ARA-C | ||||
5-FU indicates 5-fluorouracil; carbo, carboplatin; and IL-2, interleukin 2.